Study Links Estrogen-Only Menopause Therapy to Reduced Alzheimer’s Risk in Women

1-Minute Brief

The findings suggest estrogen-only hormone therapy may be associated with fewer Alzheimer’s signs and lower dementia risk in women.

Key Facts

• A Stanford study found estrogen-only menopausal hormone therapy was linked to 35% lower Alzheimer’s pathology in women.
• Later-life estrogen therapy has been associated with a lower risk of developing dementia, according to News-Medical.
• Brain autopsies revealed fewer Alzheimer’s signs in women who took estrogen-only menopause drugs.
• The same study reported a 39% lower chance of dementia among women using estrogen-only therapy.
• Multiple outlets reported that estrogen therapy is linked to fewer signs of Alzheimer’s in the brain.

What Happened

Recent studies, including one from Stanford, report that women who used estrogen-only hormone therapy for menopause showed reduced Alzheimer’s pathology and lower dementia odds.

Why It Matters

Alzheimer’s disease is a major cause of dementia in older adults. If confirmed, these findings could influence treatment decisions for menopausal women and inform future research on dementia prevention.

What's Next

Researchers may conduct further studies to confirm these associations and explore the mechanisms involved. Medical guidelines could be reviewed if additional evidence supports these findings.